Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies

25Citations
Citations of this article
102Readers
Mendeley users who have this article in their library.

Abstract

Lung cancer is one of the most common causes of cancer-related death in the world. The large number of lung cancer cases is non-small cell lung cancer (NSCLC), which approximately accounting for 75% of lung cancer. Over the past years, our comprehensive knowledge about the molecular biology of NSCLC has been rapidly enriching, which has promoted the discovery of driver genes in NSCLC and directed FDA-approved targeted therapies. Of course, the targeted therapies based on driver genes provide a more exact option for advanced non-small cell lung cancer, improving the survival rate of patients. Now, we will review the landscape of driver genes in NSCLC including the characteristics, detection methods, the application of target therapy and challenges.

Cite

CITATION STYLE

APA

Zhu, Q. G., Zhang, S. M., Ding, X. X., He, B., & Zhang, H. Q. (2017). Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies. Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.17016

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free